Pfizer joins UE 75 million additional vacancies in the second quarter | Sociedad

Pfizer at BioNTech has announced the production of 2,000 million doses of its vaccine against coronavirus, the first approved for use in the European Union, based on the 1,300 initials for this year, announced the German company BioNTech in a joint venture of a pre-meeting meeting between the German Governor and the manufacturers of the vacancies. The works to increase the production of the Pure (Belgian) plant, which proved to be in Europe, was completed, because the companies are available to increase the dose to the Union according to the calendar provided. In mid-January, Pfizer announced a temporary reduction in production rhythms for acousticators, which has provoked that the United States has reduced its doses.

In addition, BioNTech will ensure that the terms agreed upon for the first quarter of this year are completed and that the EU will receive 75 million more pinchasos in the second. The company did not specify its numbers and, according to EL PAÍS, the company did not disclose this. “We will review the totality of the doses for the first quarter and the ones we compromise on contract and have up to 75 million additional doses for the European Union in the second quarter,” said the company’s CFO, Sierk Poetting, in a statement. In Spain the correspondent exceeds 10%, depending on its population. The EU’s contract with the consortium has not been disclosed, and the calendar of the dose is discussed. Además, the editors of the communication are confused. Furthermore, there is no longer any amount of 75 million “additional” amounts of initial capacity to immunize the European population in the second quarter, and it is not clear if they are 75 million of their “additional” doses in the first quarter dose or additional ”to the compromises for the second. The only date that is known is that, in total, in 2021 BioNTech and Pfizer will add 600 million doses.

The President of the Commission, Ursula von der Leyen, announced in her Twitter account the reading of the 75 million additional doses, as in reality she was waiting for an intervention on the 8th of January. The Executive Executive, very much criticized by its management for the problems with the evacuation, has promised good news about the new dose. BioNTech ensures that the 75 million pinchazos are integrated into the brand of the new contract that Brussels announced in January and that, according to a German biotechnology spokesperson, “is currently being negotiated with the Commission”.

In addition to the modification of the productive processes in the Pure factory, BioNTech states that it can produce more doses than the plant in Marburg (Germany) has received the production license and can manufacture in February for the European Agency del Medicamento pueda validate the process. “Our European manufacturing network is constantly expanding”, added the company. In December, when the vacancy of Pfizer and BioNTech received the first authorizations, only ten companies said that there were now 13. The company will ensure that it continues to grow and that it is in talks to read new agreements.

Last week, the pharmaceutical giant Novartis announced that it would support Pfizer and BioNTech in the production of its vehicle. The companies will make an initial agreement to proportion their production capacity, which will materialize in the second quarter when the final agreement is made. The doses of the ammunition are manufactured in the Stein plant, in Switzerland.

Bayer has confirmed the loans that will be produced from 2022 onwards by the German company CureVac. “I would like to announce that we have the necessary capacity to produce the CureVac vaccine based on the ARNm”, stated this Monday in a virtual press conference in charge of Bayer’s pharmaceutical sector manager Stefan Oelrich. The company is expected to produce 160 million doses the first year.

These advertisements are produced by a very low-income vacancy in Europe, with the three vacancies returning to the EU, and criticizing the European Commission for failing to manage well the pharmaceutical companies’s. The lack of vacancies obliges to paralyze the campaign in cities like Madrid, Paris or Lisbon, and adds pressure to Brussels, defining that the pace of vacancies will recover in March.

This month the German Government and the Lederes of the Federal States will meet for a video conference to analyze the development of the holiday campaign. In addition, representatives of the pharmaceutical companies that distribute vehicles against the covid-19 in Europe and that the UE has agreed to buy by adelantado. The Minister of Health, Jens Spahn, reconciles with the diary Picture which does not create that of the meeting salga no concrete agreement.

Germany has the first dose of Pfizer and BioNTech or Modern’s vacancies to 1.9 million people (2.2% of its population), of which 461,701 have also received the second dose, according to Institute data Robert Koch. The country is managing 100,000 vacancies a day.

The most recent data recorded by Germany in the last 24 hours were 5,608 new cases of coronavirus and 175 deaths due to illness. These numbers are lower than the monthly debits to the delay in the notification and are performed during the test at the end of the week. Compared to the previous months, when 6,729 contagios were recorded, the date is lower, online with the time that is observed in the last two weeks. The accumulated incidence, which in Germany is in the form of seminal form, is 91 contagios per 100,000 inhabitants. The country maintains a long-term confinement, although not domiciled (hostel, ocean, culture, business center and closed colleges), from December onwards which will be extended to less than 14 February.

Coronavirus Information

Here you can follow the ultimate time regarding the evolution of the pandemic

– Restriction Searcher: What can I do in my municipality?

– Asia evolves the coronavirus curve in the world

– Descárguese the application of rastreo for Spain

– Actuation guide prior to transmission